Cargando…

A Novel Calcium-Mediated EMT Pathway Controlled by Lipids: An Opportunity for Prostate Cancer Adjuvant Therapy

The composition of periprostatic adipose tissue (PPAT) has been shown to play a role in prostate cancer (PCa) progression. We recently reported an inverse association between PCa aggressiveness and elevated PPAT linoleic acid (LA) and eicosapentaenoic acid (EPA) content. In the present study, we ide...

Descripción completa

Detalles Bibliográficos
Autores principales: Figiel, Sandy, Bery, Fanny, Chantôme, Aurélie, Fontaine, Delphine, Pasqualin, Côme, Maupoil, Véronique, Domingo, Isabelle, Guibon, Roseline, Bruyère, Franck, Potier-Cartereau, Marie, Vandier, Christophe, Fromont, Gaëlle, Mahéo, Karine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6896176/
https://www.ncbi.nlm.nih.gov/pubmed/31752242
http://dx.doi.org/10.3390/cancers11111814
_version_ 1783476724498956288
author Figiel, Sandy
Bery, Fanny
Chantôme, Aurélie
Fontaine, Delphine
Pasqualin, Côme
Maupoil, Véronique
Domingo, Isabelle
Guibon, Roseline
Bruyère, Franck
Potier-Cartereau, Marie
Vandier, Christophe
Fromont, Gaëlle
Mahéo, Karine
author_facet Figiel, Sandy
Bery, Fanny
Chantôme, Aurélie
Fontaine, Delphine
Pasqualin, Côme
Maupoil, Véronique
Domingo, Isabelle
Guibon, Roseline
Bruyère, Franck
Potier-Cartereau, Marie
Vandier, Christophe
Fromont, Gaëlle
Mahéo, Karine
author_sort Figiel, Sandy
collection PubMed
description The composition of periprostatic adipose tissue (PPAT) has been shown to play a role in prostate cancer (PCa) progression. We recently reported an inverse association between PCa aggressiveness and elevated PPAT linoleic acid (LA) and eicosapentaenoic acid (EPA) content. In the present study, we identified a new signaling pathway with a positive feedback loop between the epithelial-to-mesenchymal transition (EMT) transcription factor Zeb1 and the Ca(2+)-activated K(+) channel SK3, which leads to an amplification of Ca(2+) entry and cellular migration. Using in vitro experiments and ex vivo cultures of human PCa slices, we demonstrated that LA and EPA exert anticancer effects, by modulating Ca(2+) entry, which was involved in Zeb1 regulation and cancer cellular migration. This functional approach using human prostate tumors highlights the clinical relevance of our observations, and may allow us to consider the possibility of targeting cancer spread by altering the lipid microenvironment.
format Online
Article
Text
id pubmed-6896176
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-68961762019-12-23 A Novel Calcium-Mediated EMT Pathway Controlled by Lipids: An Opportunity for Prostate Cancer Adjuvant Therapy Figiel, Sandy Bery, Fanny Chantôme, Aurélie Fontaine, Delphine Pasqualin, Côme Maupoil, Véronique Domingo, Isabelle Guibon, Roseline Bruyère, Franck Potier-Cartereau, Marie Vandier, Christophe Fromont, Gaëlle Mahéo, Karine Cancers (Basel) Article The composition of periprostatic adipose tissue (PPAT) has been shown to play a role in prostate cancer (PCa) progression. We recently reported an inverse association between PCa aggressiveness and elevated PPAT linoleic acid (LA) and eicosapentaenoic acid (EPA) content. In the present study, we identified a new signaling pathway with a positive feedback loop between the epithelial-to-mesenchymal transition (EMT) transcription factor Zeb1 and the Ca(2+)-activated K(+) channel SK3, which leads to an amplification of Ca(2+) entry and cellular migration. Using in vitro experiments and ex vivo cultures of human PCa slices, we demonstrated that LA and EPA exert anticancer effects, by modulating Ca(2+) entry, which was involved in Zeb1 regulation and cancer cellular migration. This functional approach using human prostate tumors highlights the clinical relevance of our observations, and may allow us to consider the possibility of targeting cancer spread by altering the lipid microenvironment. MDPI 2019-11-18 /pmc/articles/PMC6896176/ /pubmed/31752242 http://dx.doi.org/10.3390/cancers11111814 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Figiel, Sandy
Bery, Fanny
Chantôme, Aurélie
Fontaine, Delphine
Pasqualin, Côme
Maupoil, Véronique
Domingo, Isabelle
Guibon, Roseline
Bruyère, Franck
Potier-Cartereau, Marie
Vandier, Christophe
Fromont, Gaëlle
Mahéo, Karine
A Novel Calcium-Mediated EMT Pathway Controlled by Lipids: An Opportunity for Prostate Cancer Adjuvant Therapy
title A Novel Calcium-Mediated EMT Pathway Controlled by Lipids: An Opportunity for Prostate Cancer Adjuvant Therapy
title_full A Novel Calcium-Mediated EMT Pathway Controlled by Lipids: An Opportunity for Prostate Cancer Adjuvant Therapy
title_fullStr A Novel Calcium-Mediated EMT Pathway Controlled by Lipids: An Opportunity for Prostate Cancer Adjuvant Therapy
title_full_unstemmed A Novel Calcium-Mediated EMT Pathway Controlled by Lipids: An Opportunity for Prostate Cancer Adjuvant Therapy
title_short A Novel Calcium-Mediated EMT Pathway Controlled by Lipids: An Opportunity for Prostate Cancer Adjuvant Therapy
title_sort novel calcium-mediated emt pathway controlled by lipids: an opportunity for prostate cancer adjuvant therapy
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6896176/
https://www.ncbi.nlm.nih.gov/pubmed/31752242
http://dx.doi.org/10.3390/cancers11111814
work_keys_str_mv AT figielsandy anovelcalciummediatedemtpathwaycontrolledbylipidsanopportunityforprostatecanceradjuvanttherapy
AT beryfanny anovelcalciummediatedemtpathwaycontrolledbylipidsanopportunityforprostatecanceradjuvanttherapy
AT chantomeaurelie anovelcalciummediatedemtpathwaycontrolledbylipidsanopportunityforprostatecanceradjuvanttherapy
AT fontainedelphine anovelcalciummediatedemtpathwaycontrolledbylipidsanopportunityforprostatecanceradjuvanttherapy
AT pasqualincome anovelcalciummediatedemtpathwaycontrolledbylipidsanopportunityforprostatecanceradjuvanttherapy
AT maupoilveronique anovelcalciummediatedemtpathwaycontrolledbylipidsanopportunityforprostatecanceradjuvanttherapy
AT domingoisabelle anovelcalciummediatedemtpathwaycontrolledbylipidsanopportunityforprostatecanceradjuvanttherapy
AT guibonroseline anovelcalciummediatedemtpathwaycontrolledbylipidsanopportunityforprostatecanceradjuvanttherapy
AT bruyerefranck anovelcalciummediatedemtpathwaycontrolledbylipidsanopportunityforprostatecanceradjuvanttherapy
AT potiercartereaumarie anovelcalciummediatedemtpathwaycontrolledbylipidsanopportunityforprostatecanceradjuvanttherapy
AT vandierchristophe anovelcalciummediatedemtpathwaycontrolledbylipidsanopportunityforprostatecanceradjuvanttherapy
AT fromontgaelle anovelcalciummediatedemtpathwaycontrolledbylipidsanopportunityforprostatecanceradjuvanttherapy
AT maheokarine anovelcalciummediatedemtpathwaycontrolledbylipidsanopportunityforprostatecanceradjuvanttherapy
AT figielsandy novelcalciummediatedemtpathwaycontrolledbylipidsanopportunityforprostatecanceradjuvanttherapy
AT beryfanny novelcalciummediatedemtpathwaycontrolledbylipidsanopportunityforprostatecanceradjuvanttherapy
AT chantomeaurelie novelcalciummediatedemtpathwaycontrolledbylipidsanopportunityforprostatecanceradjuvanttherapy
AT fontainedelphine novelcalciummediatedemtpathwaycontrolledbylipidsanopportunityforprostatecanceradjuvanttherapy
AT pasqualincome novelcalciummediatedemtpathwaycontrolledbylipidsanopportunityforprostatecanceradjuvanttherapy
AT maupoilveronique novelcalciummediatedemtpathwaycontrolledbylipidsanopportunityforprostatecanceradjuvanttherapy
AT domingoisabelle novelcalciummediatedemtpathwaycontrolledbylipidsanopportunityforprostatecanceradjuvanttherapy
AT guibonroseline novelcalciummediatedemtpathwaycontrolledbylipidsanopportunityforprostatecanceradjuvanttherapy
AT bruyerefranck novelcalciummediatedemtpathwaycontrolledbylipidsanopportunityforprostatecanceradjuvanttherapy
AT potiercartereaumarie novelcalciummediatedemtpathwaycontrolledbylipidsanopportunityforprostatecanceradjuvanttherapy
AT vandierchristophe novelcalciummediatedemtpathwaycontrolledbylipidsanopportunityforprostatecanceradjuvanttherapy
AT fromontgaelle novelcalciummediatedemtpathwaycontrolledbylipidsanopportunityforprostatecanceradjuvanttherapy
AT maheokarine novelcalciummediatedemtpathwaycontrolledbylipidsanopportunityforprostatecanceradjuvanttherapy